Anika Therapeutics (ANIK) to Present at the Canaccord Adams Genuity Musculoskeletal Conference on February 7  
2/2/2012 11:06:54 AM

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today announced that Chief Executive Officer Charles H. Sherwood, Ph.D is scheduled to present at the Canaccord Genuity Musculoskeletal Conference in San Francisco.